Enhancing Downstream T Cell Processing With Ksep^® Single-Use Counterflow Centrifugation 

Unlock the potential of your T cell therapies with Ksep^® 50, designed to enhance downstream processing. 

• Achieve high viability and ensure up to 98% viable T cell recovery, crucial for quality therapeutic outcomes. 

• Efficiently concentrate, wash, and harvest T cells, achieving high cell concentrations for genetic modifications. 

• Seamlessly transition from small-scale development to large-scale manufacturing. 

• Benefit from a closed, automated system that minimizes contamination risks and reduces manual errors.